Search

Search Constraints

You searched for: Author/Creator Capasso, Mario

Search Results

11. Improving the culture of safety among healthcare workers: Integration of different instruments to gain major insights and drive effective changes. (13th October 2021)

12. Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer. Issue 5 (10th September 2020)

13. Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer. Issue 5 (10th September 2020)

14. Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer. Issue 5 (10th September 2020)

15. Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer. Issue 5 (10th September 2020)

16. Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer. Issue 5 (10th September 2020)

17. Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer. Issue 5 (10th September 2020)

18. Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer. Issue 5 (10th September 2020)

19. Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer. Issue 5 (10th September 2020)

20. Kinome multigenic panel identified novel druggable EPHB4‐V871I somatic variant in high‐risk neuroblastoma. Issue 11 (26th April 2020)